Viral vaccines: new problems and prospects.
The problems are many: how best to apply the swine flu lessons to the Russian flu "invasion;" whether enough is known about the cytomegalovirus to attempt vaccine development; how to deliver established vaccines to the millions who need them.
D000547:Amantadine / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology; D006509:Hepatitis B / Q000517:prevention & control; D006801:Humans; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D007603:Jurisprudence; D009313:National Health Programs / Q000331:legislation & jurisprudence; D011129:Polyradiculoneuropathy / Q000209:etiology; D011640:Public Policy; D011819:Rabies Vaccines; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data; D014765:Viral Vaccines / Q000600:supply & distribution / Q000627:therapeutic use*
D007252:Influenza Vaccines; D011819:Rabies Vaccines; D014765:Viral Vaccines; D007372:Interferons; D000547:Amantadine